Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 28, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, Feb. 28, 2025 -- Nonmalignant gynecological diseases (NMGD) are associated with cardiovascular and/or cerebrovascular disease (C/CVD), according to a systematic review and meta-analysis published online Feb. 24 in Heart.

Giorgia Elisabeth Colombo, M.B., Ch.B., from the Ospedale Regionale di Lugano in Switzerland, and colleagues conducted a systematic literature review to examine the association between NMGD and C/CVD. A combination of ischemic heart disease, cerebrovascular disease, heart failure, and peripheral vascular disease defined the composite C/CVD outcome.

The analysis included 28 studies, with 3,271,242 participants. The researchers found that 53.3 percent of the studies had a serious/critical risk for bias. Overall, individuals with NMGD had a significantly elevated risk for composite C/CVD (summary relative risk [SRR], 1.28; I2 = 65.3 percent), ischemic heart disease (SRR, 1.41; I2 = 73.7 percent), and cerebrovascular disease (SRR, 1.33; I2 = 91.5 percent). Those with a history of endometriosis or polycystic ovary syndrome had a greater risk for C/CVD and its components in NMGD-specific analyses.

"Physicians should be aware of the potential association between NMGD and C/CVD and use this to inform clinical practice in order to mitigate the risk of C/CVD," the authors write. "Our findings reinforce the need for prospective longitudinal life course research evaluating risk of C/CVD outcomes in NMGD overall and in subgroup populations, which may catalyze primary prevention strategies."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-01 18:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords